Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.49 Up 0.04(9.60%) Dec 2, 4:00PM EST
Prev Close:0.44
Open:0.55
Bid:0.37 x 5000
Ask:0.51 x 11000
1y Target Est:0.38
Beta:-0.019043
Earnings Date:Feb 14 - Feb 20 (Est.)
Day's Range:0.45 - 0.58
52wk Range:0.25 - 1.34
Volume:6,887,656
Avg Vol (3m):591,438
Market Cap:136.95M
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICUp 9.60%136.95M
BMYUp 0.29%93.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.20
Quarterly EPS Est (Dec-16) :-0.07
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback